TF
GILD icon

Trek Financial’s Gilead Sciences GILD Stock Holding History

Trek Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08M Buy
16,440
+13,708
+502% +$1.81M 0.1% 176
2026
Q1 		$381K Sell
2,732
-12,862
-82% -$1.8M 0.02% 337
2025
Q4 		$1.91M Buy
15,594
+13,041
+511% +$1.58M 0.11% 175
2025
Q3 		$283K Buy
+2,553
New +$290K 0.02% 360
2024
Q3 		– Sell
-4,332
Closed -$297K – 416
2024
Q2 		$297K Sell
4,332
-1,279
-23% -$85.4K 0.02% 303
2024
Q1 		$411K Sell
5,611
-1,442
-20% -$111K 0.03% 253
2023
Q4 		$571K Sell
7,053
-1,508
-18% -$117K 0.05% 173
2023
Q3 		$642K Sell
8,561
-303
-3% -$23.3K 0.06% 155
2023
Q2 		$683K Sell
8,864
-1,079
-11% -$86.1K 0.06% 134
2023
Q1 		$825K Buy
9,943
+3,305
+50% +$274K 0.08% 121
2022
Q4 		$570K Sell
6,638
-127
-2% -$10.1K 0.06% 138
2022
Q3 		$417K Sell
6,765
-5,140
-43% -$324K 0.04% 141
2022
Q2 		$736K Buy
11,905
+35
+0.3% +$2.17K 0.08% 109
2022
Q1 		$706K Buy
11,870
+2,330
+24% +$149K 0.06% 112
2021
Q4 		$693K Buy
+9,540
New +$657K 0.06% 92

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trek Financial's GILD Position: Q2 2026 in Review

Trek Financial increased its Gilead Sciences (GILD) stake by 502% in Q2 2026, buying an estimated $1.81M and bringing the position to 16,440 shares worth $2.08M. The position accounts for 0.1% of the portfolio, ranked #176.

Trek Financial first reported a position in GILD in Q4 2021 and has held it in 15 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Trek Financial held 16,440 shares of Gilead Sciences worth $2.08M as of Q2 2026.
  • Trek Financial bought 13,708 Gilead Sciences shares in Q2 2026, an estimated $1.81M.
  • Gilead Sciences made up 0.1% of Trek Financial's portfolio in Q2 2026, its #176 holding.
  • Trek Financial first reported a position in Gilead Sciences in Q4 2021 and has held it in 15 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Trek Financial's 13F filing for Q2 2026, filed 13 Aug 2026.